1. Home
  2. SAVA vs VTSI Comparison

SAVA vs VTSI Comparison

Compare SAVA & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • VTSI
  • Stock Information
  • Founded
  • SAVA 1998
  • VTSI 1993
  • Country
  • SAVA United States
  • VTSI United States
  • Employees
  • SAVA N/A
  • VTSI N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • VTSI Miscellaneous manufacturing industries
  • Sector
  • SAVA Health Care
  • VTSI Consumer Discretionary
  • Exchange
  • SAVA Nasdaq
  • VTSI Nasdaq
  • Market Cap
  • SAVA 70.5M
  • VTSI 67.3M
  • IPO Year
  • SAVA N/A
  • VTSI N/A
  • Fundamental
  • Price
  • SAVA $2.05
  • VTSI $6.16
  • Analyst Decision
  • SAVA Buy
  • VTSI Strong Buy
  • Analyst Count
  • SAVA 3
  • VTSI 1
  • Target Price
  • SAVA $54.50
  • VTSI $7.00
  • AVG Volume (30 Days)
  • SAVA 1.2M
  • VTSI 77.3K
  • Earning Date
  • SAVA 08-07-2025
  • VTSI 05-12-2025
  • Dividend Yield
  • SAVA N/A
  • VTSI N/A
  • EPS Growth
  • SAVA N/A
  • VTSI N/A
  • EPS
  • SAVA N/A
  • VTSI 0.19
  • Revenue
  • SAVA N/A
  • VTSI $26,164,645.00
  • Revenue This Year
  • SAVA N/A
  • VTSI $9.92
  • Revenue Next Year
  • SAVA N/A
  • VTSI $16.54
  • P/E Ratio
  • SAVA N/A
  • VTSI $32.45
  • Revenue Growth
  • SAVA N/A
  • VTSI N/A
  • 52 Week Low
  • SAVA $1.15
  • VTSI $3.57
  • 52 Week High
  • SAVA $42.20
  • VTSI $9.40
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 51.70
  • VTSI 57.33
  • Support Level
  • SAVA $2.02
  • VTSI $6.05
  • Resistance Level
  • SAVA $2.25
  • VTSI $6.91
  • Average True Range (ATR)
  • SAVA 0.11
  • VTSI 0.37
  • MACD
  • SAVA -0.02
  • VTSI -0.02
  • Stochastic Oscillator
  • SAVA 29.03
  • VTSI 53.70

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: